Graves’ disease induced by Alemtuzumab in relapsing–remitting multiple sclerosis patients: an observational study in a reference center by Rodríguez de Vera Gómez, P., García-González, J. J., Ravé-García, R., López Ruiz, R., Torres-Cuadro, A., Eichau-Madueño, S., García-García, C., Martín-Hernández, T.

Get full text